Progress in comprehensive treatment of hepatic encephalopathy
-
摘要:
<正>肝性脑病(HE)是由严重的肝脏功能失调或障碍所引起的、以代谢紊乱为基础、中枢神经系统功能失调的综合征,其主要临床表现为意识障碍、行为异常和昏迷,严重程度差异很大。HE病因大部分是
-
[1][1]王吉耀, 徐传涛.急性肝衰竭的治疗进展[J].临床肝胆病杂志, 2007, 23 (5) ∶334-336. [2]赵和平.结肠净化对肝性脑病干预的临床研究[J].中华实验和临床病毒学杂志, 2008, 22 (3) ∶222-224. [3]Als-Nielsen B, Gluud LL, Gluud C.Non-absorbable disaccha-rides for hepatic encephalopathy:systematic review of randomized tri-als[J].BMJ, 2004, 328 (7447) ∶1046-1053. [4]Williams R, James OF, Warnes TW, et al.Evaluation of the effica-cy and safety of rifaximin in the treatment of hepatic encephalopathy:a double-blind randomized dose-finding multi-centre study[J].Eur J Gastroenterol hepatol, 2000, 12 (2) ∶203-208. [5]Ahmad I, Khan AA, Alam A, et al.L-Ornithine-L-aspartate infusion efficacy in hepatic encephalopathy[J].J Coll Physicians SurgPak, 2008, 18 (7) ∶684-687. [6]Jalan R, Wright G, Davies NA, et al.L-Ornithine phenylacetate (OP) :a novel treatment for hyperammonemia and hepatic encepha-lopathy[J].Med Hypotheses, 2007, 69 (3) ∶1064-1069. [7]Malaguarnera M, Pistone G, Elvira R, et al.Effects of L-carnitine in patients with hepatic encephalopathy[J].World J Gastroenterol, 2005, 11 (45) ∶7197-7199. [8]Koretaz RL, Als-Nielsen B, Kjaergard LL, et al.Branched-chain amino acids for hepatic encephalopathy[J].Cochrane Database Syst Rev, 2003, 56 (2) ∶1939-1945. [9]Als-Nielsen B, Gluud LL, Gluud C.Benzodiazepine receptor an-tagonists for hepatic encephalopathy[J].Cochrane Database Syst Rev, 2004, 34 (2) ∶2798-2803. [10]Sharma P, Sharma BC, Puri V, et al.An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy[J].Eur J Gastroenterol Hepatol, 2008, 20 (3) ∶506-511. [11]Bajaj JS, Saeian K, Christensen KM, et al.Probiotic yogurt for the treatment of minimal hepatic encephalopathy[J].Am J Gastroen-terol, 2008, 103 (1) ∶1707-1715. [12]Prasad S, Dhiman RK, Duseja A, et al.Lactulose improves cogni-tive functions and health-related quality of life in patients with cir-rhosis who have minimal hepatic encephalopathy[J].Hepatology, 2007, 45 (1) ∶549-559. [13]Malaguarnera M, Greco F, Barone G, et al.Bifidobacterium lon-gum with fructo-oligosaccharide (FOS) treatment in mini-mal he-patic encephalopathy:a randomized double-blind placebo controlled study[J].Dig Dis Sci, 2007, 52 (11) ∶3259-3265. [14]Katayama K.Ammonia metabolism and hepatic encephalopathy[J].Hepatol Res, 2004, 30 (2) ∶73-79. [15]Nishimum A, Umehara Y, Umehara M, et a1.Plasma exehange—based plasma recycling dialysis system as a potential platform for ar-tifcal liversupport[J].Artif Organs, 2006, 30 (8) ∶629-633.
本文二维码
计量
- 文章访问数: 2985
- HTML全文浏览量: 8
- PDF下载量: 1005
- 被引次数: 0